Paclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cells
about
Vibration from a riveting hammer causes severe nerve damage in the rat tail modelThe search for novel analgesics: targets and mechanismsOlesoxime (cholest-4-en-3-one, oxime): analgesic and neuroprotective effects in a rat model of painful peripheral neuropathy produced by the chemotherapeutic agent, paclitaxelCurrent status and future directions of botulinum neurotoxins for targeting pain processingAnimal models of peripheral neuropathiesCharacterisation of a peripheral neuropathic component of the rat monoiodoacetate model of osteoarthritisThe anti-diabetic drug metformin protects against chemotherapy-induced peripheral neuropathy in a mouse modelTargeting neuroprotection as an alternative approach to preventing and treating neuropathic painMitotoxicity in distal symmetrical sensory peripheral neuropathiesBasic science and clinical management of painful and non-painful chemotherapy-related neuropathy.Organic effects of associating paclitaxel with a lipid-based nanoparticle system on a nonhuman primate, Cebus apella.Toll-like receptor 4 signaling contributes to Paclitaxel-induced peripheral neuropathy.Peripheral neuropathy caused by Paclitaxel and docetaxel: an evaluation and comparison of symptomsLangerhans cells regulate cutaneous innervation density and mechanical sensitivity in mouse footpad.Global inhibition of reactive oxygen species (ROS) inhibits paclitaxel-induced painful peripheral neuropathy.Prevention of paclitaxel-induced allodynia by minocycline: Effect on loss of peripheral nerve fibers and infiltration of macrophages in rats.Paclitaxel-induced hyposensitivity to nociceptive chemical stimulation in mice can be prevented by treatment with minocycline.Intraepidermal nerve fiber loss corresponds to the development of taxol-induced hyperalgesia and can be prevented by treatment with minocyclineVasodilatation in the rat dorsal hindpaw induced by activation of sensory neurons is reduced by paclitaxelThe response of spinal microglia to chemotherapy-evoked painful peripheral neuropathies is distinct from that evoked by traumatic nerve injuries.Terminal arbor degeneration--a novel lesion produced by the antineoplastic agent paclitaxel.Vertebrate epidermal cells are broad-specificity phagocytes that clear sensory axon debrisProtection against oxaliplatin-induced mechanical hyperalgesia and intraepidermal nerve fiber loss by minocycline.Neurosteroid 3α-androstanediol efficiently counteracts paclitaxel-induced peripheral neuropathy and painful symptomsFollow-up psychophysical studies in bortezomib-related chemoneuropathy patients.Mitochondrial abnormality in sensory, but not motor, axons in paclitaxel-evoked painful peripheral neuropathy in the rat.Chemotherapy-evoked painful peripheral neuropathy: analgesic effects of gabapentin and effects on expression of the alpha-2-delta type-1 calcium channel subunit.Blocking the GABA transporter GAT-1 ameliorates spinal GABAergic disinhibition and neuropathic pain induced by paclitaxel.Characterization of oxaliplatin-induced chronic painful peripheral neuropathy in the rat and comparison with the neuropathy induced by paclitaxel.Effects of mitochondrial poisons on the neuropathic pain produced by the chemotherapeutic agents, paclitaxel and oxaliplatin.Ciguatoxin reduces regenerative capacity of axotomized peripheral neurons and delays functional recovery in pre-exposed mice after peripheral nerve injury.Multiple impairments of cutaneous nociceptor function induced by cardiotoxic doses of Adriamycin in the rat.Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy.Prevention of paclitaxel-evoked painful peripheral neuropathy by acetyl-L-carnitine: effects on axonal mitochondria, sensory nerve fiber terminal arbors, and cutaneous Langerhans cells.Persistent chemoneuropathy in patients receiving the plant alkaloids paclitaxel and vincristineSubclinical peripheral neuropathy is a common finding in colorectal cancer patients prior to chemotherapyNON-INVASIVE EVALUATION OF NERVE CONDUCTION IN SMALL DIAMETER FIBERS IN THE RAT.Nerve growth factor alters microtubule targeting agent-induced neurotransmitter release but not MTA-induced neurite retraction in sensory neurons.Neurogenic factor-induced Langerhans cell activation in diabetic mice with mechanical allodyniaPrevention of chemotherapy-induced peripheral neuropathy by the small-molecule inhibitor pifithrin-μ.
P2860
Q23921033-9E056A4D-E906-4912-8B0A-7201469A09E2Q24288817-CD2513F8-83AC-4283-B853-CED0F2B45BC4Q24646451-769861BB-16AE-4CEF-B7A5-9488D3C28987Q26778129-96E2BFE7-A836-4457-A1E0-3B37912F8ACDQ27028046-1BA2E37C-9041-46A6-9EAF-3B9573492675Q27306316-3275B45F-42E8-4584-8462-545CBF9B1717Q28539926-6E2E1707-635B-43B3-B123-4B58A092802EQ28820780-59F8908F-887E-4A97-869B-7B2EC6F3B868Q28834071-D4CAF975-B737-40EB-A3CC-C740492DAFD4Q33711666-05726466-DC30-4B0E-9437-3C58A9C1E547Q33719235-E5DD383E-D37A-47AF-BF0F-D6C1CB213847Q33851825-4E0CBCA1-1722-4857-A52A-C31B4695A728Q33886036-082B0BEA-2067-4B07-B790-0E927D4D3B61Q33993622-F5BBC776-2B64-4775-AFD8-521B778C015CQ34038073-9ECDA5C8-4252-4FC3-BBCB-3EA5D8DA584BQ34347705-A0F4792E-4862-43C0-B78B-9CA4B15FF4EBQ34384978-FF104E02-D088-4743-BC93-91EFF94C66F5Q34496656-960183E9-D384-4B03-934E-721978534499Q34538185-CF977426-B4E3-40D6-9F4E-C3D11DCBEFF9Q34579481-AD44FCFB-DC00-4DFF-B725-02466B600E7AQ34917256-8B71ED9B-4B2F-45FF-B830-C98674A08984Q34946226-CC8D83F0-2C1C-4DBB-899E-83F30DA3136CQ35000576-8CF178AE-B5AE-4BAA-8988-57351B95E82AQ35049356-18E77D62-A443-43CC-B316-4681D2A840B8Q35188312-EB401B1C-A763-41E5-8BA3-033CE70A3DDCQ35613627-EE67208A-9545-4FB6-BA4F-7F6ADA413415Q35652804-6F54AFBA-275E-4EFD-9549-41CD69784BC4Q35732644-B52A7346-1861-49E3-9E6B-091E3295368EQ35740234-FCB5059A-D8FB-484A-B4B1-6D704FA1A5A3Q35784775-B1D0CCB4-2119-4874-896C-6C432E67CF71Q36031157-A43E016C-C6DE-4F9C-AD59-C48DDCA51C26Q36061374-4034E7DF-156D-40C4-952F-1D98E1169A9DQ36439933-0B148F4F-313B-4104-A739-EE34057E7876Q36571464-AAEC42E2-C115-4D72-A1BE-5E8819E3611FQ36636831-A0F9C0C0-BBF9-4E0C-B5B9-035747A18F38Q36748075-2CCFD7B8-4434-461B-BCA3-5A5A230153E1Q36750823-2CC8ED37-4DAF-496A-93DE-3D3EAC40D401Q36884527-198ABF7E-8888-45FF-ACBF-794F357B7FA3Q36937533-D86166E6-61F9-4036-BB2C-D5CAE33F80E6Q36988206-C688E04F-0DD0-4175-90C1-307A1BFA5A3F
P2860
Paclitaxel- and vincristine-evoked painful peripheral neuropathies: loss of epidermal innervation and activation of Langerhans cells
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Paclitaxel- and vincristine-ev ...... activation of Langerhans cells
@ast
Paclitaxel- and vincristine-ev ...... activation of Langerhans cells
@en
type
label
Paclitaxel- and vincristine-ev ...... activation of Langerhans cells
@ast
Paclitaxel- and vincristine-ev ...... activation of Langerhans cells
@en
prefLabel
Paclitaxel- and vincristine-ev ...... activation of Langerhans cells
@ast
Paclitaxel- and vincristine-ev ...... activation of Langerhans cells
@en
P2093
P2860
P1476
Paclitaxel- and vincristine-ev ...... activation of Langerhans cells
@en
P2093
Chiang Siau
Gary J Bennett
Wenhua Xiao
P2860
P304
P356
10.1016/J.EXPNEUROL.2006.05.007
P407
P577
2006-06-22T00:00:00Z